Impruvon Health
PrivateLast Round
Seed
Jan 28, 2025
Total Funding Raised
$2.77M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Impruvon Health operates in Healthcare & Life Sciences and is based in Baltimore, Maryland. Its latest recorded funding round was a Seed round in January 2025.
Impruvon Health is a healthtech company that provides a medical technology platform for automated medication management designed for long-term care facilities and care teams for individuals with intellectual and developmental disabilities (IDD).
Sector
Healthcare & Life Sciences
Verticals
Vertical SaaS, Health IoT, Workflow Automation, Compliance
Business Model
B2B
Customer Profile
Subscription SaaS, Hardware + Subscription
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Impruvon Health Comparables
Compare Impruvon Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CaraSolva | 83% | |
| Kipu Health | 74% | |
| DosePacker | 73% |
For institutional investors. Book with your work email.
Impruvon Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 28, 2025 | ||||
| Seed | Feb 5, 2024 | ||||
| Seed | Jul 11, 2023 | ||||
| Seed | Sep 30, 2021 | ||||
| Grant | Sep 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Impruvon Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TCP Venture Capital | Seed |
| Prince William County Department of Economic Development and Tourism | Grant |
| Ford Street Ventures | Seed |
| TEDCO | Seed |
| Virginia Innovation Partnership Corporation | Seed |
| Go Global Ventures | Seed |
| University System of Maryland Momentum Fund | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 23, 2026
Grew 17% QoQ, from 35 to 41 employees.
- Aug 28, 2026
Grew 15% QoQ, from 33 to 38 employees.
For institutional investors. Book with your work email.
Impruvon Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Impruvon Health's valuation, stock price, and market status.
Is Impruvon Health a public or private company?
Impruvon Health is a private company.
What is the current stock price of Impruvon Health?
Impruvon Health is a private company, so its shares have no public market price. Caplight tracks Impruvon Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Impruvon Health worth (valuation)?
Valuation information for Impruvon Health is not publicly available.
Can I buy Impruvon Health stock?
Impruvon Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Impruvon Health's last funding round?
Impruvon Health's most recent funding round was Seed on January 28, 2025.
Who are the main investors in Impruvon Health?
Key investors in Impruvon Health include TCP Venture Capital, Ford Street Ventures.
Will Impruvon Health IPO soon?
No public IPO plans have been announced for Impruvon Health.
How can I track Impruvon Health secondary market activity?
Caplight tracks bids, offers, and trades in Impruvon Health's shares on secondary markets.